Dark Forest Capital Management LP Edwards Lifesciences Corp Transaction History

Dark Forest Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $191,433 - $252,182	2,639 New	2,639 $252,000
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $1.78 Million - $2.4 Million	25,700 New	25,700 $1.78 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $9,719 - $12,660	118 Added 3933.33%	121 $10,000
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $80,445 - $119,291	-930 Reduced 99.68%	3 $0
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $73,207 - $92,148	718 Added 333.95%	933 $109,000
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $46,270 - $56,845	-435 Reduced 66.92%	215 $28,000
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $66,891 - $79,787	650 New	650 $74,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.